• $649,788.00
    Market Cap
  • -71.00%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Income Statement
Total Operating Revenue
4,863
-35.92%
7,589
-93.96%
125,662
+228.41%
38,264
-35.76%
Cost of Revenue
948
-99.45%
173,122
-42.44%
300,757
+1,423.28%
19,744
-81.15%
Gross Profit
3,915
+102.37%
-165,533
-5.46%
-175,095
-1,045.44%
18,520
+141.01%
Sales and Marketing Expense
65,602
+533.84%
10,350
-87.14%
80,498
-41.63%
137,915
-3.79%
Research and Development Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
0
-100.00%
34,266
-18.97%
42,287
+4.88%
40,321
+19.97%
Total Operating Expenses
1.9M
-2.06%
1.9M
-7.07%
2.1M
-36.58%
3.2M
-58.72%
Operating Profit
-1.9M
-10.04%
-2.1M
-6.94%
-2.2M
-30.80%
-3.2M
-59.19%
Interest Income
-245,272
-3,503,985.71%
7
-81.58%
38
-98.39%
2,358
N/A
Interest Expense
-154,541
-49.94%
-308,741
-67.73%
-956,858
+87.20%
-511,131
+973.99%
Interest Income and Expense and Net
-399,813
+29.50%
-308,734
-67.73%
-956,820
+88.06%
-508,773
+969.03%
Total Nonoperating Income and Expense
-2.1M
+10.18%
-1.9M
+127.42%
-823,341
+48.82%
-553,260
+1,062.51%
Income before Taxes
-4.0M
+3.01%
-3.9M
+27.05%
-3.1M
-20.04%
-3.9M
-59.57%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
160,000
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-4.0M
+2.13%
-4.0M
+29.22%
-3.1M
-19.16%
-3.8M
-52.49%
Net Income from Continuing Operations Applicable to Common
-4.0M
+3.01%
-3.9M
+27.05%
-3.1M
-20.04%
-3.9M
-59.57%
Basic EPS and Net Income
-0.04
-20.00%
-0.05
0.00%
-0.05
-16.67%
-0.06
-70.00%
Diluted EPS and Net Income
-0.04
-20.00%
-0.05
0.00%
-0.05
-16.67%
-0.06
-70.00%
Basic Weighted Average Shares
107.0M
+45.87%
73.3M
+10.79%
66.2M
+9.23%
60.6M
+24.11%
Diluted Weighted Average Shares
107.0M
+45.87%
73.3M
+10.79%
66.2M
+9.23%
60.6M
+24.11%
Balance Sheet
Cash and Cash Equivalents
42,456
+5,747.93%
726
-93.41%
11,016
-90.80%
119,678
+313.82%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
42,456
+5,747.93%
726
-93.41%
11,016
-90.80%
119,678
+313.82%
Total Current Assets
68,300
+392.00%
13,882
-88.76%
123,467
-80.83%
644,183
+53.15%
Accumulated Depreciation
N/A
N/A
N/A
N/A
84,627
+0.81%
83,946
+51.97%
Property and Plant and Equipment and Net
2.3M
0.00%
2.3M
+137.35%
988,536
-1.44%
1.0M
+38.00%
Total Long-Term Assets
226,542
0.00%
226,542
+25.91%
179,927
-82.06%
1.0M
+38.00%
Total Assets
68,300
-30.93%
98,882
-96.88%
3.2M
+9.11%
2.9M
+106.25%
Income Taxes Payable
N/A
N/A
N/A
N/A
31,632
+245.25%
9,162
-51.50%
Total Short-Term Debt
72,195
-95.60%
1.6M
+93.12%
849,500
+151.83%
337,327
+169.86%
Total Current Liabilities
3.2M
-18.17%
3.9M
+30.05%
3.0M
+95.42%
1.5M
-10.51%
Total Long-Term Debt
N/A
N/A
750,000
-16.67%
900,000
+350.00%
200,000
-63.11%
Total Long-Term Liabilities
40,873
-91.68%
491,423
-52.82%
1.0M
+420.84%
200,000
+28.00%
Total Liabilities
5.3M
+35.72%
3.9M
-8.22%
4.2M
+144.79%
1.7M
-7.27%
Retained Earnings
-30.9M
+14.61%
-26.9M
+17.21%
-23.0M
+15.36%
-19.9M
+23.46%
Total Stockholders Equity
N/A
N/A
-8.3M
+43.04%
-5.8M
+91.34%
-3.1M
+56.15%
Total Shares Outstanding
108.5M
+35.96%
79.8M
+18.79%
67.2M
+2.44%
65.6M
+23.57%
Cash Flow
Cash from Operating Activities
-1.1M
-6.07%
-1.2M
-13.50%
-1.4M
-62.98%
-3.7M
+160.91%
Capital Expenditures
N/A
N/A
5,046
-88.32%
43,201
-89.01%
393,126
+528.33%
Cash from Investing Activities
-75,000
+1,386.33%
-5,046
-86.31%
-36,851
-90.50%
-388,001
+520.14%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
1.3M
+20.88%
1.1M
-19.59%
1.3M
-68.77%
4.2M
+230.94%
Financials Ratio
Gross Margin
80.51%
+103.69%
-2,181.22%
+1,465.42%
-139.34%
-387.89%
48.40%
+163.84%
Operating Margin
-38,494.63%
+40.39%
-27,419.57%
+1,440.87%
-1,779.48%
-78.93%
-8,444.76%
-36.47%
Return on Assets
-4,829.87%
+1,895.44%
-242.05%
+140.14%
-100.79%
-42.60%
-175.59%
-64.12%
Return on Equity
N/A
N/A
55.74%
-19.05%
68.86%
-54.48%
151.27%
-83.93%
Revenue Growth
-35.92%
-61.77%
-93.96%
-141.14%
228.41%
+738.65%
-35.76%
N/A
Current Ratio
0.02
+500.00%
0.004
-91.33%
0.04
-90.18%
0.42
+71.10%
Cash Ratio
0.01
+6,600.00%
0.0002
-94.59%
0.004
-95.29%
0.08
+361.76%
Debt-to-Equity Ratio
N/A
N/A
-0.29
-4.47%
-0.30
+70.15%
-0.18
-48.40%
Debt-to-Assets Ratio
N/A
N/A
24.18
+4,277.22%
0.55
+198.38%
0.19
-60.95%

Earnings & Revenue History

Debt-to-Assets

Cash Flow